Fierce Pharma Asia—J&J, Legend's new CAR-T data; Junshi's antiviral tops Pfizer's Paxlovid; Vir, WuXi end COVID pact

Fierce Pharma Asia—J&J, Legend’s new CAR-T data; Junshi’s antiviral tops Pfizer’s Paxlovid; Vir, WuXi end COVID pact
aliu
Fri, 05/27/2022 – 10:10



Source link